Intellia Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Intellia Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Intellia Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $105M, a 14.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $105M -$18.1M -14.7% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $110M -$17.8M -13.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $115M -$17.7M -13.3% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $119M +$17.5M +17.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $124M +$49.8M +67.5% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $128M +$51.8M +67.7% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $133M +$53.9M +68.1% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $101M +$19.5M +23.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $73.8M +$72.4M +5170% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $76.5M -$1.44M -1.85% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $79.1M +$40M +102% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $81.8M +$59.6M +268% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $1.4M -$22.1M -94% Jun 30, 2021 10-K 2022-02-24
Q1 2021 $77.9M +$53M +213% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $39.1M +$20M +104% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $22.2M +$1.55M +7.49% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $23.5M +$2.55M +12.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $24.9M +$3.91M +18.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $19.1M Dec 31, 2019 10-K 2021-02-26
Q3 2019 $20.7M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $20.9M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $21M Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.